上海时时彩综合走势图

About Us

Shanghai Shyndec Pharmaceutical Co.,Ltd,

Shanghai Shyndec Pharmaceutical Co.,Ltd, which was established in 1996, is a high-tech enterprise in the pharmaceutical industry which is specialized in manufacturing new drug preparation products and founded by academician of Chinese Academy of Engineering. It was listed on Shanghai stock exchange on June 16, 2004 (stock code: 600420, stock abbreviation:現代制藥). In April 2010, it entered China National Pharmaceutical Group Corporation(SINOPHARM).

In 2016-2017, according to the integration strategy ofSINOPHARM, Shanghai Shyndec Pharmaceutical Co.,Ltd positioned itself as a pharmaceutical industry platform of SINOPHARM, have actively promoted major asset restructuring matters. The main business of the "new Shyndec " wholly-owned or holding subsidiary after the reorganization has achieved nearly 10 billion level of revenue, total profit has exceeded 1 billion yuan, and the number of enterprise members has reached 30, among which 17 are secondary enterprises, 13 are tertiary and four-level enterprises.

After the reorganization, the "New Shyndec" has integrated into many high-quality industrial product lines and enterprise assets of China National Pharmaceutical Group to create a more centralized resource allocation and a clearer main business market. Focusing on the "anti-infection, cardiovascular and cerebrovascular, anti-tumor, leptin drugs, metabolism and endocrine" five areas then has formed and strengthened the "5 + X" industrial chain system with the modern characteristics and core competitiveness of Chinese medicine. The product structure of the company will be richer, the R&D strength will be further strengthened, and the market position of the enterprise has been improved by leaps and bounds.

For a year, Shanghai Shyndec Pharmaceutical Co.,Ltd has been guided by "big reorganization, large integration, great amalgamation and fully development". Through the three main paths of " big reorganization of institutional framework, great amalgamation of ideology and culture, great integration of personnel assets" to achieve the development goal of large-scale integration of the group chemical pharmaceutical industry and strive to create a platform of chemical pharmaceutical industry under the guidance of innovation.

  • Stock Code

    600420

  • Stock Abbreviation

    現代制藥

  • Company Address:

    Building 1, No. 1320, west Beijing road, Shanghai

Organizational Structure

上海时时彩综合走势图 PT游戏娱乐平台 浙江飞鱼彩票历史开奖 福建快3今天开奖号码 写字楼赚钱智能设备阿里巴巴 五子棋在线玩免费 腾讯分分彩龙虎怎么对刷 捕鱼达人3d白金弹头 彩票排列五走势图 辽宁35选7买的人多吗 北京pk10直播网站 手游竞技游戏排行榜 广州领奖福彩中心在哪里 重庆时时开奖结果龙虎 pk10精准人工计划软件 西洋棋棋子样式图纸 重庆时时彩在线直播软件